Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: a turkish experience with higher mortality and different background diseases.

Simple item page
dc.contributor.authorKısacık, Bünyamin
dc.contributor.authorPamuk, Ömer
dc.contributor.authorOnat, Ahmet Mesut
dc.contributor.authorErer, Burak
dc.contributor.authorHatemi, Gülen
dc.contributor.authorÖzgüler, Yeşim
dc.contributor.authorKılıç, Levent
dc.contributor.authorErtenli, İhsan
dc.contributor.authorCan, Meryem
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorKeser, Gökhan
dc.contributor.authorÖksel, Fahrettin
dc.contributor.authorYılmaz, Sedat
dc.contributor.authorPay, Salih
dc.contributor.authorBalkarlı, Ayşe
dc.contributor.authorÇobankara, Veli
dc.contributor.authorÇetin, Gözde Yıldırım
dc.contributor.authorSayarlıoğlu, Mehmet
dc.contributor.authorCefle, Ayşe
dc.contributor.authorYazıcı, Ayten
dc.contributor.authorAvcı, Ali Berkant
dc.contributor.authorTerzioğlu, Ender
dc.contributor.authorÖzbek, Süleyman
dc.contributor.authorAkar, Servet
dc.contributor.authorGül, Ahmet
dc.contributor.buuauthorPehlivan, Yavuz
dc.contributor.buuauthorDalkılıç, Ediz
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi.tr_TR
dc.contributor.researcheridAAG-8227-2021tr_TR
dc.date.accessioned2024-02-05T06:28:38Z
dc.date.available2024-02-05T06:28:38Z
dc.date.issued2014-10
dc.identifier.citationPehlivan, Y. vd. (2014). "Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: A turkish experience with higher mortality and different background diseases.". Arthritis & Rheumatology, Supplement: 10, Special Issue: SI, Meeting Abstract: 2157, 66, S943-S943.en_US
dc.identifier.endpageS943tr_TR
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.startpageS943tr_TR
dc.identifier.urihttps://hdl.handle.net/11452/39489
dc.identifier.volume66tr_TR
dc.identifier.wos000344384904305tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.wosSCIEen_US
dc.indexed.wosCPCISen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.ispartofseries
dc.relation.journalArthritis & Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject.wosRheumatologyen_US
dc.titleTuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: a turkish experience with higher mortality and different background diseases.en_US
dc.typeArticleen_US
dc.wos.quartileQ4 (Rheumatology)en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science